DK3277677T3
(en )
2021-05-25
1-cyano-pyrrolidine compounds as usp30 inhibitors
HRP20220075T1
(en )
2022-04-15
A liquid formulation comprising nicotine for aerosol administration
BR112016023628A2
(en )
2018-05-15
pharmaceutical compositions.
DK3236943T3
(en )
2023-04-11
COMPOSITIONS FOR ILEO-JEJUNAL DRUG ADMINISTRATION
DK3325487T3
(en )
2021-08-02
FORMULATION FOR SOFT, ANTICHOLINERGE ANALOGS
DK3297605T3
(en )
2022-06-07
TOPIC, PHARMACEUTICAL COMPOSITIONS
DK3229810T3
(en )
2020-08-17
PHOSPHOLIPID-ETHER ANALOGES AS CANCER-DISABLING MEDICINES
BR112016021012A2
(en )
2018-08-07
pharmaceutical compositions of therapeutically active compounds.
DK3332767T3
(en )
2019-06-24
Liquid inhalation formulation comprising RPL554
DK3235819T3
(en )
2020-12-07
Pyrrolopyrimidine compounds useful as JAK inhibitors
CL2014003447S1
(en )
2015-07-31
Fridge.
BR112017013156A2
(en )
2018-04-10
active compound combinations.
DK3232780T3
(en )
2021-09-13
Aqueous adjuvant compositions containing electrolyte, compositions containing an active substance and their use
BR112017012801A2
(en )
2018-04-10
active compound combinations.
BR112016026143A2
(en )
2018-08-07
methods and compositions comprising 10-hydroxy-2-decenoic acid.
DK3394045T3
(en )
2021-08-16
CO-CRYSTAL, MANUFACTURING PROCEDURE AND MEDICINE CONTAINING CO-CRYSTAL.
EP3153156A4
(en )
2018-02-14
Composition based on a stabilized solution of active ingredients
DK3204380T3
(en )
2019-11-04
HIS UNKNOWN AMINOPYRIDINE COMPOUNDS USED AS INHIBITORS OF PROTEIN PRENYLING
BR112016018071A2
(en )
2018-05-08
Larvicide composition.
FR3025096B1
(en )
2016-12-23
GEL / GEL COMPOSITION CONTAINING ANTI-TRANSPARENT ACTIVE INGREDIENT
CL2016002704A1
(en )
2017-06-30
Stable compositions of neuroactive peptides.
DK2915526T3
(en )
2021-09-06
PHARMACEUTICAL COMPOSITIONS INCLUDING ANAGRELID
FR3022292B1
(en )
2016-07-29
THERMALLY CONTROLLED TUBULAR STIFFENER
UA98845U
(en )
2015-05-12
Pharmaceutical composition comprising co-crystal of choline epalrestat
CL2016003220A1
(en )
2017-06-02
Intravaginal formulations comprising gnrh.